Wenrong Huang1 article listing Wenrong Huang in Nature Communications, indexed by Paperzzz from Crossref and OSF.Tifcemalimab as monotherapy or in combination with toripalimab in patients with relapsed/refractory lymphoma: a Phase I trial Nature Communications